Weave Bio announced a collaboration with Takeda to deploy the Weave platform across 14 active programs in multiple global markets. The collaboration brings together Weave’s AI capabilities and Takeda’s regulatory expertise to support innovation in regulatory workflows.
Press release
Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities
Related news
Press release
Weave Bio Appoints Krates Ng as Chief Technology Officer to Power Enterprise-Scale Regulatory AI
Press release
Two Former FDA Leaders Join Weave Bio’s Strategic Advisory Board
Press release
Weave Bio Enables Global Submissions From a Single Source of Truth
News